Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Expensify Inc (EXFY) vs Nasdaq Inc (NDAQ) Price & Performance

Expensify IncTrade
Nasdaq IncTrade

Price performance (Past 24H)

Key statistics

Expensify Inc vs Nasdaq Inc — how do they compare? Expensify Inc trades at $2.4 (market cap $208.82M), while Nasdaq Inc trades at $93.65 (market cap $51.63B). The key difference: Nasdaq Inc is far larger — about 247.2× Expensify Inc's market cap, and Nasdaq Inc pays a 1.26% dividend while Expensify Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Expensify Inc for 41 Days and Nasdaq Inc for 126 Days on average.

EXFYNDAQ
Market Cap
$208.82M$51.63B
Volume
456,1022,668,175
Sector
TechnologyFinancials
52-Week High
$2.72$100.98
52-Week Low
$0.75$76.85
Typical Hold Time
41 Days126 Days
Enterprise Value
$148.44M$58.09B
Dividend Yield
—1.26%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Expensify Inc

Expensify (EXFY) trades at $2.30, up 1.32% today, showing technical bullish momentum with positive moving average signals. The company reported mixed Q2 2026 results with revenue of $33.9M and improved profitability, beating EPS estimates. Recent developments include AI-native ERP integrations and European card expansion, though fundamentals show negative net margins and high P/E ratio of 258.82. Analyst consensus is bullish with a $13.75 price target, representing significant upside potential from current levels.

EXFY presents a high-risk, high-reward opportunity with strong analyst optimism contrasting with fundamental challenges. The stock's substantial discount to consensus target offers potential upside, but investors must weigh improving cash flow trends against persistent negative profitability and competitive pressures in the expense management sector.

Nasdaq Inc

Nasdaq (NDAQ) trades at $92.37, up 0.48% with a bullish technical signal. The company shows strong fundamentals with Q2 2026 EPS beating expectations at $1.07 versus $0.984, and revenue growth from $7.4B in 2024 to $8.3B in 2025. Recent news highlights Nasdaq's AI-powered Calypso platform adoption by HSBC and Moderna joining the Nasdaq-100 Index, signaling business momentum. Valuation metrics include P/E of 26.93 and P/S of 6.07, with analyst consensus price target at $110.43.

NDAQ presents a favorable outlook with consistent earnings beats and strategic AI integration driving growth. Risks include market volatility sensitivity and debt levels, but strong institutional support and bullish analyst ratings suggest upside potential. The stock's current price offers a 19.6% discount to consensus target, making it attractive for growth-oriented investors seeking exposure to financial technology and market infrastructure.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EXFY
0% Buy100% Sell
Avg holding period · 41 Days
NDAQ
51% Buy49% Sell
Avg holding period · 126 Days

Top news

Latest headlines on both assets

About Expensify Inc

Expensify Inc is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.

Read more on EXFY →

About Nasdaq Inc

Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.

Read more on NDAQ →